Clinical Trials for Drug: Sulindac

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
SWOG-S0820 A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon or Rectal Cancer, Phase III (Paces) Open